The Future Healthcare Investment Market (FHIM) 2026 will take place in Shanghai on November 4–5, 2026. This event serves as a platform for Asian hospitals, pharmaceutical and medical technology companies, investors, and healthcare organizations to engage with European healthcare institutions, procurement networks, and investors.
FHIM 2026 also facilitates connections with leading hospitals, innovation ecosystems, and capital partners in China. Confirmed participants on the procurement side include Hirslanden, EHPPA, MercurHosp, and XMED iQ, representing private hospitals, public procurement, central purchasing, and pan-European digital GPO networks.
The event offers opportunities for hospital groups and healthcare organizations across Asia to collaborate with leading hospitals and healthcare groups in China and Europe. Potential areas of cooperation encompass clinical practice, technology adoption, hospital operations, digital transformation, and international partnerships.
For investors, FHIM links Asian general partners (GPs) and limited partners (LPs) with European LPs, family offices, insurers, institutional investors, and healthcare-focused capital. This supports opportunities for fundraising, co-investment, and long-term capital partnerships.
FHIM gathers companies and projects from pharma, med tech, digital health, and healthcare services, offering direct exposure to potential investment and strategic cooperation opportunities. Med tech firms can engage with clinical validation, hospital procurement, distribution, and local partnerships. Pharma and biotech companies can connect with business development teams, investors, and clinical partners for licensing, joint development, financing, and international commercialization.
Leave a Reply